Abstract
Ample evidence suggests that hepatic macrophages play key roles in the injury and repair mechanisms during liver disease progression. There are two major populations of hepatic macrophages: the liver resident Kupffer cells and the monocyte-derived macrophages, which rapidly infiltrate the liver during injury. Under different disease conditions, the tissue microenvironmental cues of the liver critically influence the phenotypes and functions of hepatic macrophages. Furthermore, hepatic macrophages interact with multiple cells types in the liver, such as hepatocytes, neutrophils, endothelial cells, and platelets. These crosstalk interactions are of paramount importance in regulating the extents of liver injury, repair, and ultimately liver disease progression. In this review, we summarize the novel findings highlighting the impact of injury-induced microenvironmental signals that determine the phenotype and function of hepatic macrophages. Moreover, we discuss the role of hepatic macrophages in homeostasis and pathological conditions through crosstalk interactions with other cells of the liver.
Introduction
Hepatic macrophages, consisting of liver resident Kupffer cells (KCs) and monocyte-derived macrophages (MoMϕs), play a central role in maintaining homeostasis of the liver as well as contributing to the progression of acute or chronic liver injury (1). Kupffer cells are the most abundant tissue macrophages in mammalian bodies, accounting for 80–90% of total tissue macrophages (2). In the liver, KCs are distributed along the hepatic sinusoids, preferentially near the periportal areas (3). In the healthy liver, a small number of MoMϕs are located mainly in the portal triad areas (4, 5). In mouse, KCs and MoMϕs can be distinguished by their differential expression of certain cell surface markers. Kupffer cells are defined as CD11blow, F4/80hi, C-type lectin domain family 4 member F, CD68+, and CX3C chemokine receptor 1 (CX3CR1)− (6, 7). MoMϕs are CD11b+, F4/80+, Ly6C+, macrophage colony-stimulating factor 1 receptor (CSF1R)+. Human KCs are not as well-characterized and normally identified as CD68+ cells (8). Human MoMϕs are normally identified as CD14+, CC-chemokine receptor 2 (CCR2)+ cells (Table 1) (8, 9).
Table 1
| KCs | MoMϕs | |
|---|---|---|
| Origins | Fetal liver-derived erythromyeloid progenitors | Circulatory monocytes from bone marrow-derived haematopoietic stem cells |
| Location | Along the hepatic sinusoids, preferentially near the periportal area | Mainly in the portal triad of the healthy liver |
| Cell surface markers in mice | CD11blow, F4/80hi, Clec4F+, CD68+, CX3CR1− | CD11b+, F4/80+, Ly6C+, CSF1R+ |
| Cell surface markers in humans | CD68+ | CD14+, CCR2+ |
| Functional differences | Induce immune tolerance to innocuous antigens; defend against pathogens; sense alterations in tissue integrity and maintain tissue homeostasis; orchestrate tissue repair after injury; facilitate leukocyte recruitment | Contribute to anti-bacterial responses; replenish KCs after injury; co-existence of subsets with opposing functions of pro-inflammatory and anti-inflammatory; pro-fibrogenic and anti-fibrogenetic |
Difference between KCs and MoMϕs.
KCs, Kuppfer cells; MoMϕs, Monocytes-derived macrophages; CD11b, cluster of differentiation molecule 11B; Clec4f, C-type lectin domain family 4 member f; CX3CR1, CX3C chemokine receptor 1; CSF1R, Colony-stimulating factor 1 receptor; CCR2, Chemokine (C-C motif) receptor 2.
A salient function of macrophages is to remove pathogens and dead cells (3). In a healthy liver, KCs constantly phagocytose aged erythrocytes, neutrophils, and effector CD8+ T cells, thereby maintaining homeostasis within the liver (10–12). Monocyte-derived macrophages are also able to phagocytose dead endothelial cells and maintain integrity of vasculature under normal condition (13). The phagocytosis function of macrophages and its contribution to liver homeostasis and disease have been recently highlighted in an excellent review (14). Aside from phagocytosis, macrophages act as antigen-presenting cells and regulate adaptive immune responses. It is known that KCs play a central role in inducing immune tolerance to innocuous antigens that reached the liver from the intestine (15). In contrast, MoMϕs that are recruited into the liver lose the tolerogenic phenotype and instead contribute to antigen-specific proinflammatory immune responses (Table 1) (16). During liver injury, a large number of circulating monocytes infiltrate into the liver and further differentiate into MoMϕs (17). Injury-induced modulations of the liver tissue microenvironment, such as soluble mediators released by activated/stress cells and accumulation of dead cells, influence the phenotypes of both KCs and MoMϕs and determine their involvement in aggravation of liver injury or restoration of liver functions (6, 16, 17). Under healthy and disease conditions, we call any signals received from local microenvironment and prompted functional differentiation of hepatic macrophages as microenvironmental signals. Understanding how microenvironmental signals affect the heterogeneity of hepatic macrophages and how hepatic macrophages interact with other cells during liver injury is instrumental not only in gaining basic knowledge but also in designing therapeutic strategies to treat liver diseases. In this review, we summarize the latest findings about specific environmental signals that impact the phenotype and function of hepatic macrophages and discuss the functions of hepatic macrophages in healthy and diseased liver through interacting with other cells.
Origin of Hepatic Macrophages
The recent development and improvement of research tools have allowed us to gain novel insights into the origin of hepatic macrophages. Contrary to the notion that KCs are originated solely from bone marrow–derived circulating monocytes (18), recent evidence suggests that KCs are mainly derived from yolk sac erythromyeloid progenitors (EMPs). Erythromyeloid progenitors colonize the fetal liver at E8.5 and give rise to macrophage precursors (pMacs) at E9.5 in a CX3CR1-dependent manner. A distinct transcriptional programming involving the upregulation of DNA binding 3 (Id3) is important in the further differentiation of pMacs into KCs (19). With regard to the maintenance of tissue-resident macrophages including KCs, an interesting “niche competition” model has been put forth. This model proposes that bone marrow–derived circulating monocytes and EMPs have an almost identical potential to develop into KCs and that they compete for a restricted number of niches. However, during liver development, the majority of liver niches are taken by EMPs and few by monocytes. At steady state, the niches in liver are self-maintained and tightly controlled by specific Maf transcription repressors and enhancers (20). However, when a significant number of KCs die or depleted experimentally, circulating monocytes have been shown to contribute to the KCs pool, suggesting that circulating monocytes have the potential as their embryonic counterparts to develop into KCs (21–23).
Monocyte-derived macrophages are derived from circulatory monocytes, which are developed from bone marrow–resident hematopoietic stem cells (23). Hematopoietic stem cells first differentiate into common lymphoid progenitors and then into granulocyte–monocyte progenitors (24, 25). Granulocyte–monocyte progenitors further give rise to common monocyte progenitors (cMoPs) under the regulation of macrophage CSF-1 (26). Eventually, cMoPs differentiate into circulatory monocytes. These distinct steps of hepatic stellate cell (HSC) differentiation into monocytes are tightly regulated by a number of transcription factors and epigenetic DNA methylation mechanisms (23). In mice, there are two subsets of monocytes in the liver: Ly6Chi and Ly6Clow monocytes. The Ly6Chi monocytes can differentiate into Ly6Clow monocytes, which can further differentiate into MoMϕs (27, 28). In humans, the CD14hiCD16− and CD14−CD16hi monocytes correlate with Ly6Chi and Ly6Clow monocytes in mice, respectively (29).
Impact of Tissue Microenvironmental Factors on Hepatic Macrophages
Irrespective of the cellular origins of hepatic macrophages, they differentiate into different phenotypes depending on the stimulatory signals in the tissue environment (30). In disease conditions, there are two major types of stimulatory signals (Table 2), including danger-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs).
Table 2
| Examples | Reported in liver diseases | References | |
|---|---|---|---|
| DAMPs | HMGB-1 | AILI, I/R injury, NASH | (31–36) |
| HSP-70 | AILI | (37, 38) | |
| Bile acids | Cholestatic liver disease | (39–43) | |
| Histones | I/R injury | (44) | |
| FFAs | NASH | (45) | |
| mtDNA | NASH | (45) | |
| PAMPs | Bacteria-derived products, e.g. LPS | ALD, NASH | (46–49) |
| Hepatitis virus, e.g. HBV, HCV, HEV | Hepatitis virus infection | (50–52) | |
| Phagocytosis of cellular debris | Apoptotic cells | LPS/D-gal-induced hepatitis, CCL4-induced liver fibrosis, ALD | (53–55) |
Microenvironment in the liver.
DAMPs, danger-associated molecular patterns; PAMPs, pathogen-associated molecular patterns; HMGB-1, high mobility group box 1; HSP-70, heat shock protein 70; FFAs, free fatty acids; mtDNA, mitochondrial DNA; LPS, Lipopolysaccharides; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus; AILI, Acetaminophen-induced liver injury; I/R, Ischemia/Reperfusion; NASH, Non-alcoholic steatohepatitis; ALD, Alcoholic liver disease.
Danger-associated molecular patterns are a diverse group of molecules including nucleic acid in various conformations (e.g., single-/double-stranded RNA or DNA), nuclear proteins [e.g., high mobility group box 1 (HMGB1)], cytosolic proteins [e.g., heat shock protein 70 (HSP-70)], purine nucleotides [e.g., adenosine triphosphate (ATP)], or mitochondrial compounds (e.g., mtDNA, N-formyl peptides). Danger-associated molecular patterns are recognized by pathogen recognition receptors (PRRs), which are expressed on hepatic macrophages and can activate the cells (56, 57). These PRR receptors include Toll-like receptors (TLRs), nucleotide-binding oligomerization domain–like receptors (NLRs), and retinoic acid-inducible gene 1–like receptors (56). Danger-associated molecular patterns play a critical role in activating macrophages during sterile liver injury, which can be caused by a variety of stimuli, such as overdose of acetaminophen (APAP), cholestatic obstruction, excess accumulation of free fatty acids (FFAs), or hepatic ischemia, and reperfusion (I/R) (31, 58). The release of DAMPs is common in these situations, and it may be an active process from viable or dying cells, or a passive process leaking out from necrotic cells (56).
In APAP-induced liver injury (AILI), hepatocyte damage leads to the release of HMGB1, which activates KCs to produce proinflammatory cytokines and chemokines (31). High mobility group box 1 is a nuclear-binding protein that can function as a DNA chaperone in nucleus, sustaining autophagy in cytosol and DAMP molecule outside the cell (32). High mobility group box 1–deficient mice show less inflammation and neutrophil recruitment post-APAP treatment when compared to their wild-type counterparts (31, 33). Mice lacking the receptor for advanced glycation end products, a receptor for HMGB1, on bone marrow–derived cells display a similar phenotype as the HMGB1-deficient mice (31, 33). Together, these data indicate that HMGB1 activates KCs and contributes to AILI (31, 33). Aside from HMGB1, HSP-70 has also been reported to be released by necrotic hepatocytes during AILI (37). Heat shock protein 70 is an important component of cellular machinery, facilitating protein folding, but also an inducible stress-response protein that can undergo translocation to the cell surface or is released into the extracellular milieu during cellular stress or necrotic death (38). Heat shock protein 70 can stimulate macrophages to promote immune response and inflammation (37).
Similar to the necroinflammatory injury pattern in AILI, cholestatic liver disease is also characterized by hepatocytes necrosis (59). Lesions in bile duct canaliculi cause an increase of bile acids, which result in liver injury, but appear to drive KCs into anti-inflammatory state (39, 59). Bile acids can bind to G-protein–coupled bile acid receptor (TGR5), which is expressed on hepatic macrophages (40). Activation of TGR5 in macrophages reduces proinflammatory cytokines while maintaining anti-inflammatory cytokines (41). The anti-inflammatory effect of TGR5 on macrophages is mediated by inhibiting nuclear factor κB and JNK signaling pathways and NLRP3 inflammasome (41, 43).
Hepatic I/R injury is another example of sterile tissue injury in which DAMPs are released. It is reported that after I/R injury hepatocytes actively secrete HMGB1, which binds to TLR4 and activates KCs (34). In addition to HMGB1, other DAMPs, such as histones, DNA fragments, ATP, and mitochondrial reactive oxygen species (ROS), also activate KCs via different PRRs, such as TLR9 (recognizing histones) (44), TLR3 (recognizing RNA) (60, 61), TLR4 (recognizing HSP-70) (62), and nucleotide-binding domain leucine-rich repeat containing family pyrin domain containing 3 (NLRP3) (recognizing ATP) (63, 64). As a result, KCs secrete ample proinflammatory cytokines to exacerbate I/R injury (65).
Non-alcoholic steatohepatitis (NASH) is characterized by steatosis with tissue injury and inflammation (35). Increased accumulation of fat in hepatocytes leads to lipotoxicity, which induces apoptotic and necrotic death of hepatocytes with concomitant release of DAMPs, such as HMGB1 and FFAs (35). Released HMGB1 activates KCs via TLR4 as in other liver injury cases (35, 36). Free fatty acids decrease the mitochondrial membrane potential and subsequently induce mtDNA release from the mitochondria to the cytoplasm (45). Released mtDNA causes NLRP3 inflammasome activation in KCs, which further promotes the production of proinflammatory interleukin 1β (IL-1β) (45).
Pathogen-associated molecular patterns include pathogen-specific polysaccharides, lipoproteins, and nucleic acids. They bind to PPRs expressed on hepatic macrophages and trigger inflammatory activation of these cells (66). In alcoholic liver disease (ALD), excess chronic ingestion of alcohol increases gut permeability and causes translocation of bacteria-derived products, such as lipopolysaccharides (LPSs), from the gut to the liver (67). Lipopolysaccharide binds to CD14 in association with TLR4 on KCs to initiate proinflammatory signaling (46). Numerous studies have demonstrated that KCs play a central role in alcohol-induced inflammation and injury of the liver (27, 28). Kupffer cells produce cytokines such as tumor necrosis factor α (TNF-α) and free radicals to promote ALD (68, 69). In addition to KCs, MoMϕs can be differentiated from the circulating monocytes that are recruited into the liver as a result of the inflammatory response during liver injury (28). Two types of MoMϕs (Ly6Clow MoMϕs and Ly6Chi MoMϕs) have been reported to coexist in the liver of mice after chronic alcohol feeding. The Ly6Clow MoMϕs exhibit restorative phenotype, whereas Ly6Chi MoMϕs exhibit proinflammatory phenotype. A large dose of alcohol binge after chronic alcohol feeding enhances liver inflammation and injury with an increased ratio of Ly6Chi/Ly6Clow MoMϕ. Moreover, Ly6Chi MoMϕ switches to Ly6Clow MoMϕ upon phagocytosis of apoptotic hepatocytes. Taken together, KCs and MoMϕ are involved in the pathogenesis of ALD (27, 28, 70).
Whereas, translocation of LPS from the gut lumen to portal circulation in ALD may result from direct alcohol toxicity to intestinal epithelium (67), increased exposure to intestinal LPS has also been considered in the pathogenesis of NASH (71). Increased levels of LPS in the portal circulation have been observed during NASH development (72). The role of LPS-TLR4 signaling in non-alcoholic fatty liver disease (NAFLD) has been demonstrated in a number of studies (47). Toll-like receptor 4 expression on KCs is elevated both in patients with NASH and mice fed with methionine–choline–deficient diet (47, 48). Depletion of KCs by clodronate liposomes significantly reduced TLR4 expression and steatohepatitis (47). Together, endotoxin appears to play an important role in NAFLD through TLRs on KCs, particularly TLR4. However, the function of MoMϕ in response to endotoxin during NAFLD remains unclear.
Hepatitis virus infection is a leading cause of chronic liver diseases (49). Hepatitis B virus (HBV) modulates liver macrophage functions to favor viral replication and survival. These modulations include reduced production of antiviral cytokine IL-1β and enhanced levels of immunosuppressive IL-10 (73). Hepatitis C virus (HCV) can enter KCs through phagocytic uptake. Subsequently, viral RNA triggers myeloid differentiation primary response gene 88 (MyD88)–mediated TLR7 signaling to induce IL-1β expression. Hepatitis C virus uptake concomitantly induces a potassium efflux that activates the NLRP3 inflammasome and promotes the secretion of activated IL-1β. Interleukin 1β produced by KCs contributes to HCV disease severity (74). It has also been reported that the function of monocytes/macrophages is impaired in pregnant patients with hepatitis E virus (HEV)–induced acute hepatitis (50). Toll-like receptor 3 and TLR7 expressions are reduced, and MyD88 downstream molecules, IRF3 and IRF7, are decreased in macrophages from these patients (50). The macrophage phagocytic activity and Escherichia coli–induced ROS production are significantly impaired in macrophages from HEV patients as well (50). These data suggest that the impact of viruses on hepatic macrophages could result in immune suppression and/or inflammation and tissue damage.
Phagocytosis of Dead Cells
A salient function of macrophages is to remove dead cells and cellular debris, which is a key initial step in resolving tissue inflammation and promoting tissue repair from injury. It has been widely reported that phagocytosis of dead cells triggers transcriptional reprogramming of macrophages to switch from a proinflammatory to an anti-inflammatory and tissue restorative phenotype. For example, it is shown that the membrane-bound transforming growth factor β (TGF-β) on apoptotic cells can trigger KCs to produce IL-10, which suppresses the proinflammatory immune response in a mouse model of LPS/d-galactosamine–induced hepatitis (51, 52). In a mouse model of ALD, it is reported that phagocytosis of cellular debris triggers hepatic macrophages to switch from proinflammatory to an anti-inflammatory phenotype (28). Similarly, in a mouse model of carbon tetrachloride–induced liver fibrosis, phagocytosis of cellular debris induces Ly6Chi proinflammatory, profibrotic MoMϕs to differentiate into antifibrotic macrophages (52). The restorative macrophages are the most abundant subset in the liver during maximal fibrosis resolution and represent the predominant source of matrix metalloproteinases. Moreover, it has been demonstrated that phagocytosis of necrotic hepatocytes by macrophages activates Wnt ligand secretion, thereby promoting liver regeneration (53).
In summary, the particular function of KCs and MoMϕ is tightly regulated by microenvironmental signals, such as DAMPs and PAMPs. The same signals may play a similar role in different liver diseases; for example, HMGB1 released by hepatocytes triggers KC activation in AILI, I/R, and NASH, indicating similar functions of macrophages in various liver diseases (32–34, 37, 54, 56, 58, 75, 76). In certain liver diseases, such as NAFLD and ALD, DAMPs and PAMPs coexist to regulate macrophage functions (35, 56, 77, 78) However, more studies are warranted to better understand the differential functions of KCs and MoMϕs in a given disease situation.
Communication Between Hepatic Macrophages and Other Cells in the Liver
There are five major cell types in the liver including hepatocytes, biliary epithelial cells (cholangiocytes), liver sinusoidal endothelial cells (LSECs), KCs, and HSCs (66, 79). Hepatocytes account for roughly 80% of the liver's mass (79), and they perform a number of vital functions, including protein synthesis, detoxification, and metabolism of lipids and carbohydrates (79). Cholangiocytes are another type of epithelial cells in the liver, lining the lumen of the bile ducts (79). Liver sinusoidal endothelial cells form the lining of the smallest blood vessels in the liver, part of the reticuloendothelial system (79). Liver sinusoidal endothelial cells regulate the passage of molecules from the blood vessels into the liver (79). Hepatic stellate cells are found in the space of Disse, between hepatocytes and LSECs. Hepatic stellate cells can transdifferentiate from a quiescent state to an activated, highly proliferative, and wound-healing myofibroblast (80). In addition, there are a variety of other immune cells such as monocytes, neutrophils, and platelets that contribute to liver homeostasis as well as disease progression (66). In different types and stages of liver diseases, hepatic macrophages are critically involved in the progression and regression via close communication with other cells in the liver (Table 3) (108).
Table 3
| Interacted cell types | Roles of hepatic macrophages in interaction | Reported in liver diseases | References | |
|---|---|---|---|---|
| KCs | Hepatocytes | KCs activate Notch signaling in hepatocytes | ICC | (81) |
| Hepatocytes | KCs are essential for proliferation of liver progenitor cells | Choline-deficient, ethionine-supplemented diet-mediated liver injury | (82) | |
| Hepatocytes | KCs trigger hepatocytes senescence | ALD | (83) | |
| Hepatocytes | KC are activated by hepatocytes-derived extracellular vesicles | ALD | (84, 85) | |
| HSCs | KCs activate HSCs and modulate fibrogenic responses in HSCs | Liver fibrosis | (86, 87) | |
| HSCs | KCs secrete IFN-γ to induce apoptosis of HSCs | Liver fibrosis | (88) | |
| HSCs | HSCs induce KCs differentiation and decrease its cytokine secretion | Liver fibrosis | (89) | |
| LSECs | KCs are essential for LSECs' uptake of hyaluronic acid | In vitro culture | (90) | |
| MoMϕs | KCs produce CCL2 to recruit MoMϕs | Amodiaquine-induced liver injury | (91) | |
| Neutrophils | The production of TNF-α and TGF-β by KCs is promoted by neutrophil-secreted IL-17; Express adhesion molecules to recruit neutrophils | Cholestatic liver injury, LPS-induced liver injury | (92, 93) | |
| NKT cells | KCs produce IL-1β to recruit and activate NKT cells | Alcoholic steatosis | (94) | |
| CD4+ T cells | KCs produce ROS, IL-6 and TNF-α to recruit CD4+ T cells. | Hepatic I/R injury | (95) | |
| T cells | KCs produce IL-10, TGF-β, ROS, IDO, PGE2/J2 to induce and maintain T cell tolerance or apoptosis | Liver transplantation, HBV infection, in vitro culture | (96–101) | |
| CD8+ T cells | KCs prime CD8+ T cells to differentiate into effector cells to kill viruses | HBV infection | ||
| Platelets | KCs promote adhesion of platelets on the KCs to encase the bacteria and facilitate anti-bacterial responses | Bacteria infection in the liver | ||
| MoMϕs | cholangiocytes | MoMϕs release IL-6 to promote the proliferation of cholangiocytes | Cholestatic liver disease | (102, 103) |
| cholangiocytes | MoMϕs are recruited by cholangiocytes-derived osteopontin and MCP-1 | Partial Hepatectomy | (104) | |
| LSECs | LSECs are activated by MoMϕs | Partial Hepatectomy | (105) | |
| NKT cells | MoMϕs promote NKT cells over-activation and cell death | NAFLD | (106) | |
| NKT cells | MoMϕs produce IL-12 to activate NKT cells, which inhibits liver regeneration | Partial hepatectomy | (107) |
The crosstalk of hepatic macrophages with other cells in the liver.
KCs, Kuppfer cells; MoMϕs, Monocytes-derived macrophages; LSECs, liver sinusoidal endothelial cells; HSCs, hepatic stellate cells; NKT cells, natural killer T cell; IFN-γ, Interferon-gamma; CCL2, chemokine (C-C motif) ligand 2; TNF-α, tumor necrosis factor alpha; TGF-β, transforming growth factor beta; IL-17, interleukin 17; IL-1β, interleukin 1 beta; IL-6, interleukin 6; IL-10, interleukin 10; ROS, reactive oxygen species; IDO, indoleamine 2,3-dioxygenase; PGE2/J2, prostaglandin E2/J2; MCP-1, monocyte chemoattractant protein-1; ICC, intrahepatic cholangiocarcinoma; LPS, lipopolysaccharides; HBV, hepatitis B virus; I/R, ischemia/reperfusion.
Crosstalk Between Hepatic Macrophages and Hepatocytes
The crosstalk between hepatic macrophages and hepatocytes has been indicated in a number of studies. In a mouse model of thioacetamide (TAA)–induced intrahepatic cholangiocarcinoma, KCs accumulate around the central vein area and express Notch ligand Jagged-1 rapidly after the initiation of the TAA treatment, coinciding with the activation of Notch signaling in pericentral hepatocytes. Depletion of KCs prevents the Notch-mediated hepatocytes transformation to cholangiocytes, suggesting that KCs contribute to the cell fate change in hepatocytes (109). Another study has also demonstrated that KCs are required for the proliferation of liver progenitor cells that can differentiate into hepatocytes in a model of choline-deficient, ethionine-supplemented diet–mediated liver injury and regeneration (110). In ALD, it is shown that KC-produced IL-6 triggers hepatocyte senescence, which becomes resistant to apoptosis (81). Interestingly, recent studies also support that hepatocytes communicate with macrophages through the release of extracellular vesicles (EVs) that contain proteins and microRNAs (82, 83). In vitro studies using HepG2 cells have demonstrated that alcohol treatment induces an elevated release of EVs, which activate THP-1 cells, a human leukemia monocytic cell line into a proinflammatory phenotype through CD40 ligand (83). Another study also showed that exosomes derived from alcohol-treated hepatocytes mediated the transfer of liver-specific miRNA-122 to monocytes and sensitized monocytes to LPS stimulation (82). These studies suggest that hepatocytes release EVs that contain altered proteins and miRNAs to regulate the activation of monocytes/macrophages.
Interactions of Hepatic Macrophages With Cholangiocytes, HSCs, and LSECs
Macrophages secrete IL-6 during infection, and IL-6 can induce cholangiocyte proliferation leading to ductular reaction (84, 85). On the other hand, cholangiocytes are the major source of osteopontin and macrophage chemoattractant protein 1, which acts as chemotaxis to recruit MoMϕs during partial hepatectomy (102). Hepatic stellate cells and KCs are located in close proximity to each other (86, 103). In a mouse model of CCl4-induced liver fibrosis, it is shown that depletion of hypoxia-inducible factor 1α in HSCs inhibits KC activation and reduces the release of proinflammatory cytokines, suggesting a function of HSCs in regulating KCs during liver fibrosis (87). On the other hand, KCs have also been reported to modulate HSC functions. Chemokine (C-X-C motif) ligand 6 stimulates the phosphorylation of epidermal growth factor receptor and the expression of TGF-β in KCs, which further activates HSCs and results in liver fibrosis (103). It is reported that ROS and IL-6 activate KCs, which in turn modulate fibrogenic responses of HSCs (104). Activated KCs secrete interferon γ, which subsequently induces HSC apoptosis in a STAT1-dependent manner and reduces liver fibrosis (111). Liver sinusoidal endothelial cells are the major source of intercellular adhesion molecule 1 (ICAM-1). In partial hepatectomy, ICAM-1 expressed on KCs and LSECs recruits leukocytes, which leads to TNF-α and IL-6 production, thereby promoting hepatocyte proliferation (89). Moreover, MoMϕs also play an important role in activating LSECs and contributing to vascular growth and liver regeneration (88). Kupffer cell depletion inhibits hyaluronic acid uptake by LSECs and impairs sinusoidal integrity, suggesting there is a crosstalk between KCs and LSECs (37, 112).
Interactions of Macrophages With Other Hepatic Immune Cells
Kupffer cell activation by pathogens results in CCL2 secretion, which promotes the recruitment of monocytes into the injured liver (105). It has been reported that alcohol treatment of THP-1 cells or human primary monocytes triggers the secretion of EVs, which induce the differentiation of naive monocytes into anti-inflammatory macrophages by delivering cargos, such as miR-27a (90).
Neutrophils are the most abundant white blood cells in the circulation, and they are recruited to the liver in various injury conditions (91). During cholestatic liver injury, neutrophils secrete IL-17, which promotes the production of TNF-α and TGF-β by KCs. On the other hand, KCs express adhesion molecules that induce neutrophil attachment and facilitate bacterial clearance in the liver (113). Another study reported that KCs coordinate with LSECs for neutrophil adhesion, recruitment, and activation through TLR4 during LPS-induced liver injury (78).
Natural killer T (NKT) cells are a group of “unconventional” T cells that express both natural killer (NK) cell receptors and T cell receptors. In the NASH liver, lipid accumulation causes an increase of the number of MoMϕs and activates the cells to a proinflammatory phenotype. Activated MoMϕs promote NKT cell activation and induce NKT cell deficiency, contributing to the pathogenesis of NAFLD (93). The importance of KC/NKT interaction in liver regeneration has also been described. After partial hepatectomy, MoMϕs produce IL-12 to activate hepatic NKT cells, which prohibit liver regeneration (114). In ALD, NLRP3 inflammasome activation results in IL-1β release by KCs. Released IL-1β recruits and activates hepatic invariant NKT cells, which promote liver inflammation, neutrophil infiltration, and liver injury (106). Furthermore, ample evidence supports the importance of macrophages in interacting with conventional T cells. It has been shown that KCs trigger the recruitment of CD4+ T cells by ROS, IL-6, and TNF-α (107). Kupffer cells express high levels of MHC class II and act as antigen-presenting cells. In fact, a number of studies have shown that KCs play an important role in inducing and maintaining T cell tolerance, through producing tolerogenic mediators such as IL-10, TGF-β, ROS, indoleamine 2,3-dioxygenase, prostaglandin E2/J2 (94, 97). Moreover, it is reported that during liver transplantation KCs induce T cell apoptosis and thus promote immune tolerance (98). After HBV infection, KCs produce IL-10 and support liver tolerance by inducing anti-HBV CD8+ T cell exhaustion (99). A recent study demonstrated that the induction of endoplasmic reticulum stress in HCC cell lines induces the secretion of EVs. The HCC-derived EVs induce elevated expression of programmed death ligand 1 on macrophages in vivo and in vitro, which causes T cell dysfunction and impaired proliferation (100). Recent studies showed that priming CD8+ T cells by KCs leads to the differentiation of CD8+ T cells into effector cells that have powerful killing activities against hepatitis viruses, such as HBV (101).
Moreover, interesting interactions between macrophages and platelets have been unveiled (115). Under basal conditions, platelets form transient “touch-and-go” interactions with von Willebrand factor constitutively expressed on KCs (115). During bacterial infection, platelets switch from “tough-and-go” to sustained GPIIb-mediated adhesion on the KCs to encase the bacteria and facilitate anti-bacterial responses (115).
In summary, hepatic macrophages interact with almost all cell types of the liver. In naive state, KCs, through these interactions, play a critical role in maintaining tissue homeostasis. Under injury or disease conditions, the crosstalk of macrophages with hepatocytes, cholangiocytes, LSECs, HSCs, and other immune cells contributes to exacerbation of tissue damage or promotion of liver repair and regeneration, depending on the cell type and signaling pathways involved.
Statements
Author contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication. ZS wrote the draft. CJ revised the manuscript.
Funding
CJ received funding from NIH (DK109574, DK121330, DK122708, AA021723, and AA024636) and support from a University of Texas System Translational STARs award. ZS received funding from YNU Double first class university plan (C1762201000142).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
JuCTackeF. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol. (2016) 13:316–27. 10.1038/cmi.2015.104
2.
BilzerMRoggelFGerbesAL. Role of Kupffer cells in host defense and liver disease. Liver Int. (2006) 26:1175–86. 10.1111/j.1478-3231.2006.01342.x
3.
AbdullahZKnollePA. Liver macrophages in healthy and diseased liver. Pflugers Arch. (2017) 469:553–60. 10.1007/s00424-017-1954-6
4.
TheurlIHilgendorfINairzMTymoszukPHaschkaDAsshoffMet al. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med. (2016) 22:945–51. 10.1038/nm.4146
5.
GammellaEBurattiPCairoGRecalcatiS. Macrophages: central regulators of iron balance. Metallomics. (2014) 6:1336–45. 10.1039/C4MT00104D
6.
ScottCLZhengFDe BaetselierPMartensLSaeysYDe PrijckSet al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. (2016) 7:10321. 10.1038/ncomms10321
7.
LavinYWinterDBlecher-GonenRDavidEKeren-ShaulHMeradMet al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. (2014) 159:1312–26. 10.1016/j.cell.2014.11.018
8.
KrenkelOTackeF. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. (2017) 17:306–21. 10.1038/nri.2017.11
9.
Dal-SeccoDWangJZengZKolaczkowskaEWongCHPetriBet al. A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. J Exp Med. (2015) 212:447–56. 10.1084/jem.20141539
10.
TerpstraVvan BerkelTJ. Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood. (2000) 95:2157–63. 10.1182/blood.V95.6.2157
11.
ShiJLFujiedaHKokuboYWakeK. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology. (1996) 24:1256–63. 10.1002/hep.510240545
12.
CrispeINDaoTKlugewitzKMehalWZMetzDP. The liver as a site of T-cell apoptosis: graveyard, or krilling field?Immunol. Rev. (2000) 174:47–62. 10.1034/j.1600-0528.2002.017412.x
13.
CarlinLMStamatiadesEGAuffrayCHannaRNGloverLVizcay-BarrenaGet al. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell. (2013) 153:362–75. 10.1016/j.cell.2013.03.010
14.
HorstAKTiegsGDiehlL. Contribution of macrophage efferocytosis to liver homeostasis and disease. Front Immunol. (2019) 10. 10.3389/fimmu.2019.02670
15.
CrispeIN. Immune tolerance in liver disease. Hepatology. (2014) 60:2109–17. 10.1002/hep.27254
16.
HeymannFPeusquensJLudwig-PortugallIKohlheppMErgenCNiemietzPet al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology. (2015) 62:279–91. 10.1002/hep.27793
17.
ZigmondESamia-GrinbergSPasmanik-ChorMBrazowskiEShiboletOHalpernZet al. Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol. (2014) 193:344–53. 10.4049/jimmunol.1400574
18.
van FurthRCohnZA. The origin and kinetics of mononuclear phagocytes. J Exp Med. (1968) 128:415–35. 10.1084/jem.128.3.415
19.
MassEBallesterosIFarlikMHalbritterFGuntherPCrozetLet al. Contribution of macrophage efferocytosis to liver homeostasis and disease. Science. (2016) 353:aaf4238. 10.1126/science.aaf4238
20.
SoucieELWengZGeirsdottirLMolawiKMaurizioJFenouilRet al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells. Science. (2016) 351:aad5510. 10.1126/science.aad5510
21.
SawaiCMBabovicSUpadhayaSKnappDLavinYLauCMet al. Hematopoietic stem cells are the major source of multilineage hematopoiesis in adult animals. Immunity. (2016) 45:597–609. 10.1016/j.immuni.2016.08.007
22.
GuilliamsMScottCL. Does niche competition determine the origin of tissue-resident macrophages?Nat Rev Immunol. (2017) 17:451–60. 10.1038/nri.2017.42
23.
EavesCJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood. (2015) 125:2605–13. 10.1182/blood-2014-12-570200
24.
AuffrayCFoggDKNarni-MancinelliESenechalBTrouilletCSaederupNet al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med. (2009) 206:595–606. 10.1084/jem.20081385
25.
LiuKVictoraGDSchwickertTAGuermonprezPMeredithMMYaoKet al. In vivo analysis of dendritic cell development and homeostasis. Science. (2009) 324:392–7. 10.1126/science.1170540
26.
DaiXMRyanGRHapelAJDominguezMGRussellRGKappSet al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. (2002) 99:111–20. 10.1182/blood.V99.1.111
27.
WangMFraschSCLiGFengDGaoBXuLet al. Role of gp91(phox) in hepatic macrophage programming and alcoholic liver disease. Hepatol Commun. (2017) 1:765–779. 10.1002/hep4.1078
28.
WangMYouQLorKChenFGaoBJuC. Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J Leukoc Biol. (2014) 96:657–65. 10.1189/jlb.6A0114-004RR
29.
IngersollMASpanbroekRLottazCGautierELFrankenbergerMHoffmannRet al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood. (2010) 115:e10–9. 10.1182/blood-2009-07-235028
30.
XueJSchmidtSVSanderJDraffehnAKrebsWQuesterIet al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. (2014) 40:274–88. 10.1016/j.immuni.2014.01.006
31.
HuebenerPHernandezCSchwabeRF. HMGB1 and injury amplification. Oncotarget. (2015) 6:23048–9. 10.18632/oncotarget.5243
32.
ChenRCHouWZhangQHKangRFanXGTangDL. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol. Med. (2013) 19:357–66. 10.2119/molmed.2013.00099
33.
HuebenerPPradereJPHernandezCGwakGYCavigliaJMMuXet al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest. (2015) 125:539–50. 10.1172/JCI76887
34.
TsungASahaiRTanakaHNakaoAFinkMPLotzeMTet al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. (2005) 201:1135–43. 10.1084/jem.20042614
35.
ArreseMCabreraDKalergisAMFeldsteinAE. Innate immunity and inflammation in NAFLD/NASH. Dig Dis Sci. (2016) 61:1294–303. 10.1007/s10620-016-4049-x
36.
LiLChenLHuLLiuYSunHYTangJet al. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology. (2011) 54:1620–30. 10.1002/hep.24552
37.
Martin-MurphyBVHoltMPJuC. The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. Toxicol Lett. (2010) 192:387–94. 10.1016/j.toxlet.2009.11.016
38.
WallinRPLundqvistAMoreSHvon BoninAKiesslingRLjunggrenHG. Heat-shock proteins as activators of the innate immune system. Trends Immunol. (2002) 23:130–5. 10.1016/S1471-4906(01)02168-8
39.
FiorucciSBiagioliMZampellaADistruttiE. Bile acids activated receptors regulate innate immunity. Front Immunol. (2018) 9:1853. 10.3389/fimmu.2018.01853
40.
PerinoASchoonjansK. TGR5 and Immunometabolism: Insights from Physiology and Pharmacology. Trends Pharmacol Sci. (2015) 36:847–57. 10.1016/j.tips.2015.08.002
41.
ReichMKlindtCDeutschmannKSpomerLHaussingerDKeitelV. Role of the G protein-coupled bile acid receptor TGR5 in liver damage. Dig Dis. (2017) 35:235–40. 10.1159/000450917
42.
LouGMaXFuXMengZZhangWWangYDet al. GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells. PLoS ONE. (2014) 9:e93567. 10.1371/journal.pone.0093567
43.
WangYDChenWDYuDFormanBMHuangW. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology. (2011) 54:1421–32. 10.1002/hep.24525
44.
HuangHEvankovichJYanWNaceGZhangLRossMet al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology. (2011) 54:999–1008. 10.1002/hep.24501
45.
PanJOuZCaiCLiPGongJRuanXZet al. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. Cell Immunol. (2018) 332:111–20. 10.1016/j.cellimm.2018.08.006
46.
RaoR. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology. (2009) 50:638–44. 10.1002/hep.23009
47.
RiveraCAAdegboyegaPvan RooijenNTagalicudAAllmanMWallaceM. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. (2007) 47:571–9. 10.1016/j.jhep.2007.04.019
48.
EmontzpohlCStoppeCTheissenABeckersCNeumannUPLurjeGet al. The role of macrophage migration inhibitory factor in remote ischemic conditioning induced hepatoprotection in a rodent model of liver transplantation. Shock. (2019) 52:e124–e34. 10.1097/SHK.0000000000001307
49.
BernalWAuzingerGDhawanAWendonJ. Acute liver failure. Lancet. (2010) 376:190–201. 10.1016/S0140-6736(10)60274-7
50.
SehgalRPatraSDavidPVyasAKhanamAHissarSet al. Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure. Hepatology. (2015) 62:1683–96. 10.1002/hep.28143
51.
ZhangMXuSHanYCaoX. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-beta. Hepatology. (2011) 53:306–16. 10.1002/hep.24029
52.
RamachandranPPellicoroAVernonMABoulterLAucottRLAliAet al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA. (2012) 109:E3186–95. 10.1073/pnas.1119964109
53.
BoulterLGovaereOBirdTGRadulescuSRamachandranPPellicoroAet al. Macrophage-derived Wnt opposes notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. (2012) 18:572–9. 10.1038/nm.2667
54.
AlisiACarsettiRNobiliV. Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development. Hepatology. (2011) 54:1500–2. 10.1002/hep.24611
55.
EvankovichJChoSWZhangRCardinalJDhuparRZhangLet al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem. (2010) 285:39888–97. 10.1074/jbc.M110.128348
56.
MihmS. Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. Int J Mol Sci. (2018) 19:E3104. 10.3390/ijms19103104
57.
ShiYEvansJERockKL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. (2003) 425:516–21. 10.1038/nature01991
58.
AntoineDJWilliamsDPKiparAJenkinsREReganSLSathishJGet al. High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci. (2009) 112:521–31. 10.1093/toxsci/kfp235
59.
LiMCaiSYBoyerJL. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. (2017) 56l:45–53. 10.1016/j.mam.2017.06.001
60.
KarikoKNiHCapodiciJLamphierMWeissmanD. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. (2004) 279:12542–50. 10.1074/jbc.M310175200
61.
CavassaniKAIshiiMWenHSchallerMALincolnPMLukacsNWet al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med. (2008) 205:2609–21. 10.1084/jem.20081370
62.
CalderwoodSKGongJMurshidA. Extracellular HSPs: the complicated roles of extracellular HSPs in immunity. Front Immunol. (2016) 7:159. 10.3389/fimmu.2016.00159
63.
NomuraJSoATamuraMBussoN. Intracellular ATP decrease mediates NLRP3 inflammasome activation upon nigericin and crystal stimulation. J Immunol. (2015) 195:5718–24. 10.4049/jimmunol.1402512
64.
BaronLGombaultAFannyMVilleretBSavignyFGuillouNet al. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death Dis. (2015) 6:e1629. 10.1038/cddis.2014.576
65.
ChangWJToledo-PereyraLH. Toll-like receptor signaling in liver ischemia and reperfusion. J Invest Surg. (2012) 25:271–7. 10.3109/08941939.2012.687802
66.
GaoBJeongWITianZ. Liver: an organ with predominant innate immunity. Hepatology. (2008) 47:729–36. 10.1002/hep.22034
67.
ParlesakASchaferCSchutzTBodeJCBodeC. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. (2000) 32:742–7. 10.1016/S0168-8278(00)80242-1
68.
IimuroYGallucciRMLusterMIKonoHThurmanRG. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. (1997) 26:1530–37. 10.1002/hep.510260621
69.
ZhongZConnorHStachlewitzRFVonFrankenbergMMasonRPLemastersJJet al. Role of free radicals in primary nonfunction of marginal fatty grafts from rats treated acutely with ethanol. Mol Pharmacol. (1997) 52:912–19. 10.1124/mol.52.5.912
70.
JuCLiangpunsakulS. Role of hepatic macrophages in alcoholic liver disease. J Investig Med. (2016) 64:1075–7. 10.1136/jim-2016-000210
71.
ThuySLadurnerRVolynetsVWagnerSStrahlSKonigsrainerAet al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. (2008) 138:1452–5. 10.1093/jn/138.8.1452
72.
BaffyG. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. (2009) 51:212–23. 10.1016/j.jhep.2009.03.008
73.
Faure-DupuySDelphinMAillotLDimierLLebosseFFresquetJet al. Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection. J Hepatol. (2019) 71:1086–98. 10.1016/j.jhep.2019.06.032
74.
NegashAARamosHJCrochetNLauDTDoehleBPapicNet al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. (2013) 9:e1003330. 10.1371/journal.ppat.1003330
75.
DragomirACLaskinJDLaskinDL. Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1. Toxicol Appl Pharmacol. (2011) 253:170–7. 10.1016/j.taap.2011.04.003
76.
McDonaldKAHuangHTohmeSLoughranPFerreroKBilliarTet al. Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling. Mol Med. (2015) 20:639–48. 10.2119/molmed.2014.00076
77.
GanzMSzaboG. Immune and inflammatory pathways in NASH. Hepatol Int. (2013) 7(Suppl 2):771–81. 10.1007/s12072-013-9468-6
78.
McDonaldBJenneCNZhuoLKimataKKubesP. Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia. Am J Physiol Gastrointest Liver Physiol. (2013) 305:G797–806. 10.1152/ajpgi.00058.2013
79.
TreftsEGannonMWassermanDH. The liver. Curr Biol. (2017) 27:R1147–51. 10.1016/j.cub.2017.09.019
80.
TsuchidaTFriedmanSL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastro Hepat. (2017) 14:397–411. 10.1038/nrgastro.2017.38
81.
WanJBenkdaneMAlonsELotersztajnSPavoineC. M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease. Am J Pathol. (2014) 184:1763–72. 10.1016/j.ajpath.2014.02.014
82.
Momen-HeraviFBalaSKodysKSzaboG. Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep. (2015) 5:9991. 10.1038/srep09991
83.
VermaVKLiHWangRHirsovaPMushrefMLiuYet al. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. (2016) 64:651–60. 10.1016/j.jhep.2015.11.020
84.
ParkJTadlockLGoresGJPatelT. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology. (1999) 30:1128–33. 10.1002/hep.510300522
85.
XiaoYWangJYanWZhouYChenYZhouKet al. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling. J Hepatol. (2015) 62:889–96. 10.1016/j.jhep.2014.10.033
86.
WeiskirchenRTackeF. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr. (2014) 3:344–63.
87.
MochizukiAPaceARockwellCERothKJChowAO'BrienKMet al. Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia-inducible factor-1alpha-dependent manner by modulating macrophage phenotype in mice. J Immunol. (2014) 192:3847–57. 10.4049/jimmunol.1303195
88.
Melgar-LesmesPEdelmanER. Monocyte-endothelial cell interactions in the regulation of vascular sprouting and liver regeneration in mouse. J Hepatol. (2015) 63:917–25. 10.1016/j.jhep.2015.05.011
89.
SelznerNSelznerMOdermattBTianYVan RooijenNClavienPA. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology. (2003) 124:692–700. 10.1053/gast.2003.50098
90.
SahaBMomen-HeraviFKodysKSzaboG. MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem. (2016) 291:149–59. 10.1074/jbc.M115.694133
91.
Prame KumarKNichollsAJWongCHY. Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease. Cell Tissue Res. (2018) 371:551–65. 10.1007/s00441-017-2753-2
92.
BendelacASavagePBTeytonL. The biology of NKT cells. Annu Rev Immunol. (2007) 25:297–336. 10.1146/annurev.immunol.25.022106.141711
93.
TangTSuiYLianMLiZHuaJ. Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death. PLoS ONE. (2013) 8:e81949. 10.1371/journal.pone.0081949
94.
YouQChengLKedlRMJuC. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. (2008) 48:978–90. 10.1002/hep.22395
95.
GrohmannUFallarinoFBianchiRBelladonnaMLVaccaCOrabonaCet al. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol. (2001) 167:708–14. 10.4049/jimmunol.167.2.708
96.
BissellDMWangSSJarnaginWRRollFJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest. (1995) 96:447–55. 10.1172/JCI118055
97.
KnollePAUhrigAProtzerUTripplerMDuchmannRzum BuschenfeldeKHMet al. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology. (1998) 27:93–9. 10.1002/hep.510270116
98.
ChenGSQiHZ. Effect of Kupffer cells on immune tolerance in liver transplantation. Asian Pac J Trop Med. (2012) 5:970–972. 10.1016/S1995-7645(12)60184-9
99.
LiMSunRXuLYinWWChenYYZhengXDet al. Kupffer cells support hepatitis B virus-mediated CD8(+) T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice. J Immunol. (2015) 195:3100–9. 10.4049/jimmunol.1500839
100.
LiuJFanLYuHZhangJHeYFengDet al. Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology. (2019) 70:241–58. 10.1002/hep.30607
101.
BenechetAPDe SimoneGDi LuciaPCilentiFBarbieraGLe BertNFumagalliVet al. Dynamics and genomic landscape of CD8(+) T cells undergoing hepatic priming. Nature. (2019) 574:200–5. 10.1038/s41586-019-1620-6
102.
WenYFengDWuHLiuWLiHWangFet al. Defective initiation of liver regeneration in osteopontin-deficient mice after partial hepatectomy due to insufficient activation of IL-6/Stat3 pathway. Int J Biol Sci. (2015) 11:1236–47. 10.7150/ijbs.12118
103.
CaiXLiZZhangQQuYXuMWanXet al. CXCL6-EGFR-induced Kupffer cells secrete TGF-beta1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis. J Cell Mol Med. (2018) 22:5050–61. 10.1111/jcmm.13787
104.
NietoN. Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology. (2006) 44:1487–501. 10.1002/hep.21427
105.
MakAUetrechtJ. Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury. J Immunotoxicol. (2019) 16:28–33. 10.1080/1547691X.2018.1516014
106.
CuiKLYanGXXuCFChenYYWangJZhouRBet al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1 beta in mice. J Hepatology. (2015) 62:1311–8. 10.1016/j.jhep.2014.12.027
107.
HanschenMZahlerSKrombachFKhandogaA. Reciprocal activation between CD4(+) T cells and Kupffer cells during hepatic ischemia-reperfusion. Transplantation. (2008) 86:710–8. 10.1097/TP.0b013e3181821aa7
108.
TackeFWeiskirchenR. Liver immunology: new perspectives. Hepatobiliary Surg Nutr. (2014) 3:330. 10.3978/j.issn.2304-3881.2014.11.07
109.
TeradaMHorisawaKMiuraSTakashimaYOhkawaYSekiyaSet al. Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma. Sci Rep. (2016) 6:34691. 10.1038/srep34691
110.
ElsegoodCLChanCWDegli-EspostiMAWikstromMEDomenichiniALazarusKet al. Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology. (2015) 62:1272–84. 10.1002/hep.27977
111.
JeongWIParkORadaevaSGaoB. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology. (2006) 44:1441–51. 10.1002/hep.21419
112.
DeaciucIVBagbyGJLangCHSpitzerJJ. Hyaluronic acid uptake by the isolated, perfused rat liver: an index of hepatic sinusoidal endothelial cell function. Hepatology. (1993) 17:266–72. 10.1002/hep.1840170217
113.
GregorySHCousensLPvan RooijenNDoppEACarlosTMWingEJ. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. J Immunol. (2002) 168:308–15. 10.4049/jimmunol.168.1.308
114.
WuXSunRChenYZhengXBaiLLianZet al. Oral ampicillin inhibits liver regeneration by breaking hepatic innate immune tolerance normally maintained by gut commensal bacteria. Hepatology. (2015) 62:253–64. 10.1002/hep.27791
115.
WongCHJenneCNPetriBChrobokNLKubesP. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol. (2013) 14:785–92. 10.1038/ni.2631
Summary
Keywords
Kupffer cells, monocyte-derived macrophages, liver injury, microenvironmental cues, cellular crosstalk
Citation
Shan Z and Ju C (2020) Hepatic Macrophages in Liver Injury. Front. Immunol. 11:322. doi: 10.3389/fimmu.2020.00322
Received
12 December 2019
Accepted
10 February 2020
Published
17 April 2020
Volume
11 - 2020
Edited by
Ralf Weiskirchen, RWTH Aachen University, Germany
Reviewed by
Dechun Feng, National Institute on Alcohol Abuse and Alcoholism (NIAAA), United States; Lynette Beattie, The University of Melbourne, Australia; Manabu Kinoshita, National Defense Medical College, Japan
Updates
Copyright
© 2020 Shan and Ju.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cynthia Ju changqing.ju@uth.tmc.edu
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.